Effects of Sensorimotor Training on Pain Intensity, Perceived Balance Confidence and Functional Exercise Capacity in Breast Cancer Patients with Chemotherapy-Induced Peripheral Neuropathy

What this Trial Is About

Researchers are evaluating the effects of sensorimotor training on pain intensity, perceived balance confidence, and functional exercise capacity in female breast cancer patients experiencing chemotherapy-induced peripheral neuropathy (CIPN). CIPN is a common side effect of chemotherapy, causing sensory and motor symptoms in 30-70% of cases. This study aims to understand how targeted exercise interventions may help manage these symptoms in women diagnosed with invasive ductal carcinoma stages I-III who have completed chemotherapy treatment and are medically stable. The trial is a single-blinded randomized controlled study involving 22 participants divided into two groups. One group performs sensorimotor training with progressively challenging balance exercises on unstable surfaces for 45 minutes twice a week over 6 weeks. The other group receives conventional exercise therapy including range of motion, stretching, strengthening, deep breathing, and aerobic exercises with the same frequency and duration. Both interventions are supervised and aim to improve balance, reduce pain, and enhance functional exercise capacity. Participants undergo assessments before and after the 6-week intervention. Evaluations include the Numeric Pain Rating Scale for pain intensity, the Timed Up and Go (TUG) test for balance, the Activities-Specific Balance Confidence Scale for perceived balance confidence, and the 6-Minute Walk Test for functional exercise capacity. Additional measures include quality of life questionnaires and neurological tests. The study tracks improvements in these areas to assess the impact of sensorimotor training compared to conventional therapy.

Effects of Sensorimotor Training With Chemotherapy-Induced Peripheral Neuropathy in Breast Cancer Patients